JP Morgan Chase’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,200
Closed -$91K – 6579
2022
Q3
$91K Buy
+3,200
New +$82.3K ﹤0.01% 5323

Other funds holding CCRN

JP Morgan Chase's CCRN Position: Q2 2026 in Review

JP Morgan Chase reduced its Cross Country Healthcare (CCRN) stake by 64% in Q2 2026, selling an estimated $884K and leaving 42,070 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #5021.

JP Morgan Chase first reported a position in CCRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $47.9M in Q4 2015. 150 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • JP Morgan Chase held 42,070 shares of Cross Country Healthcare worth $556K as of Q2 2026.
  • JP Morgan Chase sold 74,600 Cross Country Healthcare shares in Q2 2026, an estimated $884K.
  • Cross Country Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5021 holding.
  • JP Morgan Chase first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Cross Country Healthcare position peaked at $47.9M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.